Biosimilar Medicines

Zydus to Commercialize FDA-Approved Interchangeable Lucentis Biosimilar NUFYMCO in U.S. Under Bioeq Deal

The licensing deal makes Zydus the U.S. marketer and keeps Bioeq responsible for manufacturing and supply.